Kambo Frog Poisoning in Mexico
DOI:
https://doi.org/10.31157/an.v28i1.415Keywords:
Phyllomedusa bicolorAbstract
Introduction: Kambo is the skin secretion of the toxic Brazilian frog Phyllomedusa bicolor and has been practiced its inoculation through the human skin worldwide, especially in South America, by curiosity or to cure multiple diseases. Objective: Report a case of poisoning in a current ritual with Kambo frog poison. Results: 41-year-old male, Marijuana user with a last consumption three months ago. He used Kambo for generalized anxiety disorder with panic attacks and claustrophobia. He suffered complications, including neuropathy, that we associate to the toxic effect of Kambo. He received oral prednisone, diphenidol and paroxetine as treatment with improvement. Discussión: The substances that can be related to the neuropathy are tachykinin through the B receptors that participate in mechanisms linked to pain, dermorphins and deltorphins, Mu opioid agonists that act on Mu and Delta receptors of the central nervous system involved in analgesic effects, exist two phases have been described in Kambo intoxication: the first phase (usually 15-30 minutes) and the second phase, that include the persistence of acute symptoms, syndrome of inappropriate antidiuretic hormone secretion, acute toxic hepatitis, and dermatomyositis. Our patient presented the classic acute symptoms, however, he had focal sensory neuropathy. Conclusion: Clinicians need to be aware of the complications of this shamanic ritual expanding worldwide.
References
Majić T, Sauter M, Bermpohl F, Schmidt TT. Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective experiences. Journal of Psychopharmacology. 2021;35(4):421–36. DOI: 10.1177/0269881121991554. DOI: https://doi.org/10.1177/0269881121991554
Jan M Keppel H. Kambo and its Multitude of Biological Effects: Adverse Events or Pharmacological Effects? International Archives of Clinical Pharmacology. 2018;4(1):1–6. DOI: 10.23937/2572-3987.1510017. DOI: https://doi.org/10.23937/2572-3987.1510017
da Silva FVA, Monteiro WM, Bernarde PS. “Kambô” frog (Phyllomedusa bicolor): Use in folk medicine and potential health risks. Revista da Sociedade Brasileira de Medicina Tropical. 2019;52:3–4. DOI: 10.1590/0037-8682-0467-2018 DOI: https://doi.org/10.1590/0037-8682-0467-2018
Schmidt TT, Reiche S, Hage CLC, Bermpohl F, Majić T. Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports. Scientific Reports. 2020;10:21544. DOI: 10.1038/s41598-020-78527-4 DOI: https://doi.org/10.1038/s41598-020-78527-4
Alamos MF, Walker RH, Miranda M. Life-threatening risk of using Kambó in alternative medicine. Neurology: Clinical Practice. 2020;10(4):e35–7. DOI: 10.1212/CPJ.0000000000000749. DOI: https://doi.org/10.1212/CPJ.0000000000000749
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.